Expand your lab’s capabilities and rapidly increase coverage of a variety of in-demand metabolomics and lipid assays, while significantly reducing development times and the operating costs of running a wide range of assays. The Waters Targeted Omics Library, including the MetaboQuan-R and LipidQuan-R Rapid Targeted Omics Method packages, is an on-line database of method files and application notes for a variety of in-demand metabolite and lipid panels.
Browsing: mass spectrometry
In this interview, Nico and Chad (PRA Health Sciences; NC, USA) discuss the advantages, disadvantages and challenges they face with the technologies they utilize, before predicting what the future holds for the field.
Rob Wheller, Principal Scientist from LGC (Fordham, UK), discusses his current research focuses; the advantages, disadvantages and challenges of the technologies he utilizes; and advice he would give to young, early-career scientists.
In this interview, Lawrence Goodwin (KCAS, KS, USA) explains his passion for tandem technology, the portfolio of services that KCAS offers and the advantages and disadvantages of their key technologies chromatography and mass spectrometry.
New service agreement between Owlstone Medical and AstraZeneca, Biosensis launch new BDNF/proBDNF biomarker kit and the 8th Conference on Current Trends in Mass Spectrometry and Chromatography is announced
Read time: 2 mins
Read more about the top bioanalytical news stories from this week, including news from Owlstone Medical, AstraZeneca and Biosensis.
In this second part of our first ‘In the lab’ series, Scott Summerfield, Worldwide Head of Bioanalysis at GlaxoSmithKline (Ware, UK), talks through his five top tips and tricks for mass spectrometry.
View time: 5 mins
In this first part of our first ‘In the lab’ series Scott Summerfield, Worldwide Head of Bioanalysis at GlaxoSmithKline (Ware, UK), talks through the basics of mass spectrometry.
Quantitative whole body autoradiography (QWBA) and imaging mass spectrometry (IMS): can IMS replace QWBA to support regulated drug discovery and development
Read time: 4:45 mins
Eric Solon (Madrigal Pharmaceuticals; PA, USA) discusses whether or not IMS can replace QWBA as the technique of choice when examining the disposition of new drug and biotherapeutic entities.
In this review, the authors discuss supercritical fluid chromatography and review the advantages and disadvantages of the method.